ArticleJournal of thrombosis and thrombolysis2024

The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo.

Juergen Grafeneder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.